Anthem Biosciences Ltd

Anthem Biosciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 21 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 September 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

With a decisive break above Rs 970, Anthem Biosciences Ltd has surged to a fresh 52-week high of Rs 977 on 09 Sep 2026, marking a significant milestone in its price momentum amid a challenging broader market backdrop.

Extending its recent gains, Anthem Biosciences Ltd touched a fresh all-time high of Rs 977 on 09 Sep 2026, outperforming the broader Sensex which declined 0.62% on the same day. This milestone caps a strong rally that has seen the stock rise 49.25% year-to-date, significantly outpacing the sector and market benchmarks.

With a decisive surge to Rs 970.8 on 4 Sep 2026, Anthem Biosciences Ltd has reached a fresh 52-week and all-time high, marking a notable milestone in its price momentum. This advance comes amid a backdrop of strong technical signals and sustained upward trends across multiple moving averages.

After opening with a 2% gap up, Anthem Biosciences Ltd touched a fresh all-time high of Rs 970.80 on 04 Sep 2026, marking a significant milestone in its recent rally despite a slight intraday pullback.

Surpassing its previous peak, Anthem Biosciences Ltd touched a fresh 52-week high of Rs 954 on 3 Sep 2026, marking a significant milestone in its price momentum. This advance comes amid a backdrop of strong technical signals and sustained upward movement across multiple timeframes.

Anthem Biosciences Ltd has reached a significant milestone by touching its all-time high price of ₹954.60 on 03 Sep 2026, reflecting robust performance and sustained bullish momentum in the Pharmaceuticals & Biotechnology sector.

Anthem Biosciences Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underscored by positive signals across key technical indicators including MACD, moving averages, and Bollinger Bands, suggesting strengthening price momentum amid a robust market backdrop.

Extending its recent gains, Anthem Biosciences Ltd touched a fresh all-time high of Rs 951.6 on 02 Sep 2026, outperforming its sector and the broader market with a 2.97% rise on the day.

With a decisive surge to Rs 951 on 2 Sep 2026, Anthem Biosciences Ltd has reached a fresh 52-week and all-time high, marking a significant milestone in its price momentum. This rally comes amid a broader market backdrop where the Sensex has been under pressure, underscoring the stock’s relative strength and technical resilience.

Anthem Biosciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish trend. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a nuanced market sentiment as the stock price advances to ₹923.15, up 3.55% on 2 Sep 2026.

The Sensex edged up 0.26% on 1 Sep 2026, while Anthem Biosciences Ltd surged 5.09%, outperforming its Pharmaceuticals & Biotechnology sector by 5.67 percentage points. This sharp single-session gain stands out as a stock-specific event in a market where broader indices have been under pressure recently.

Anthem Biosciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 21 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

With a decisive break above Rs 939.3 on 27 Aug 2026, Anthem Biosciences Ltd has reached a fresh 52-week and all-time high, propelled by a confluence of bullish technical indicators and sustained price momentum.

Anthem Biosciences Ltd has reached a new pinnacle, touching an all-time high of Rs.936 on 27 August 2026, underscoring the company’s robust performance within the Pharmaceuticals & Biotechnology sector. This milestone reflects sustained investor confidence and a strong upward trajectory in the stock’s valuation over recent months.

The Sensex edged lower by 0.04% on 26 Aug 2026, while Anthem Biosciences Ltd surged 5.35%, touching an intraday high of Rs 922. This 4.62 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a market-wide lift.